Sequencing the Full-Length of the Phosphatase and Tensin Homolog (PTEN) Gene in Hepatocellular Carcinoma (HCC) Using the 454 GS20 and Illumina GA DNA Sequencing Platforms
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Phosphatase and tensin homolog (PTEN) is a tumor-suppressor gene that is mutated in cancer of the liver, pancreas, endometrium, and prostate. PTEN-dependent pathways are involved in mediating cell growth and invasion. To sequence the whole gene (including introns and exons), we have taken advantage of new technologies that allow for rapid, inexpensive sequencing to great depth.
DNA from 15 HCC specimens were pooled, and long-range PCR was performed by using the GeneAmp XL PCR kit. Primer parameters included: length of 20–30 base pairs (bp), melting temperature of −68°C, and G/C content of 50–60%. PCR products were then column-purified and pooled, and DNA libraries were prepared for “shotgun sequencing” on both the 454 GS and Illumina GA sequencing platforms.
We successfully amplified approximately 98.9% of the PTEN gene by using one long-range PCR protocol applied to 24 primer sets, resulting in 20 amplicons ~6.5 kilobases (kb) in length, 2 amplicons ~10 kb in length, and 2 amplicons ~2.5 kb in length. Sequencing of fragmented PCR products on both sequencing platforms identified six high-frequency SNPs that were catalogued in dbSNP as known variants.
Shotgun sequencing based on a single long-range PCR protocol in pooled samples is an efficient and relatively inexpensive way to sequence an entire gene.
- Greenman C, Stephens P, Smith R et al (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153–158 CrossRef
- Sjoblom T, Jones S, Wood L et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274 CrossRef
- Margulies M, Egholm M, Altman WE et al (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376–380
- Maehama T, Dixon JE (1999) PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 9:125–128 CrossRef
- Bae JJ, Rho JW, Lee TJ et al (2007) Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients. Oncol Rep 18:1007–1013
- Kawamura N, Nagai H, Bando K et al (1999) PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors. Jpn J Cancer Res 90:413–418
- Carnero A, Blanco-Aparicio C, Renner O et al (2008) The PTEN/PI3 K/AKT signaling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8:187–198 CrossRef
- Wang L, Wang WL, Zhang Y et al (2007) Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res 37:389–396 CrossRef
- Hu TH, Huang CC, Lin PR et al (2003) Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97:1929–1940 CrossRef
- Sequencing the Full-Length of the Phosphatase and Tensin Homolog (PTEN) Gene in Hepatocellular Carcinoma (HCC) Using the 454 GS20 and Illumina GA DNA Sequencing Platforms
World Journal of Surgery
Volume 33, Issue 4 , pp 647-652
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA
- 2. Human Genome Sequencing Center, Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA